Count | |
6 | |
5 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
33 | |
31 | |
37 | |
27 | |
101 | |
1 | |
36 | |
1 | |
2 | |
7 | |
30 | |
40 | |
1 | |
8 | |
17 | |
1 | |
1 | |
4 | |
2 | |
1 | |
1 | |
1 | |
3 | |
3 | |
4 | |
1 | |
6 | |
1 | |
2 | |
2 | |
3 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
1 | |
2 | |
2 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
Arginine/adverse effects/*analogs & derivatives/blood/*drug effects | 1 |
Phosphoproteins/adverse effects/*antagonists & inhibitors/drug effects | 1 |
C-Reactive Protein/adverse effects/*drug effects/*metabolism | 1 |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
14 | |
1 | |
1 | |
1 | |
3 | |
3 | |
2 | |
1 | |
3 | |
14 | |